Cartiva vs Toe Fusion – Why Surgeons Now Prefer Fusion After Cartiva Failures
Cartiva vs Toe Fusion – Why Surgeons Are Returning to a Proven Approach
For years, the Cartiva Synthetic Cartilage Implant was promoted as a breakthrough in treating big toe arthritis, or hallux rigidus. It promised motion preservation, faster recovery, and lasting pain relief-something traditional toe fusion could not offer. But after thousands of failures and a nationwide recall in 2024, many orthopedic surgeons are urging patients to reconsider the tried-and-true fusion procedure.
In clinics and operating rooms across the country, doctors are saying the same thing: when it comes to long-term results, toe fusion remains the most reliable option. This article compares both procedures head-to-head, highlighting the medical evidence, expert opinions, and patient outcomes that have reshaped surgical thinking. You can also visit our Comprehensive Cartiva Lawsuit and Recall Overview for the broader context behind these findings.
What Each Procedure Does
Cartiva Implant Surgery: The Cartiva implant is a small hydrogel plug inserted into the joint space of the big toe. It is meant to cushion the bones and preserve motion. The material, made from polyvinyl alcohol (PVA), was marketed as a durable alternative to fusion. The procedure takes less than an hour, and patients can typically bear weight sooner than after a fusion.
Toe Fusion (Arthrodesis): In a fusion procedure, the damaged cartilage is removed and the two bones are permanently joined using screws or a plate. The goal is to eliminate movement in the arthritic joint and therefore remove the pain source. While it sacrifices flexibility, it restores stability and allows most patients to walk comfortably once healed.
The Early Promise of Cartiva
When Cartiva received FDA clearance in 2016, it was celebrated as a modern solution. Early marketing materials claimed success rates above 85%, with faster recovery and natural motion. Many surgeons and patients embraced the innovation. The appeal was understandable: keep the joint mobile and avoid the stiffness of fusion.
However, real-world outcomes did not match the early enthusiasm. Within a few years, reports of pain, swelling, and implant failure became common. Some patients needed revision surgery within months. Others experienced implant shrinkage or migration, leading to renewed bone-on-bone contact. Studies began to show revision rates far higher than expected-sometimes exceeding 60% within a few years. The growing number of failed implants eventually led to the 2024 recall, covered in detail in The Cartiva Implant Recall Explained.
What the Data Shows Now
Recent medical studies paint a clearer-and more sobering-picture of Cartiva’s performance:
- A 2023 review published in the Journal of Foot & Ankle Surgery found that nearly 60% of Cartiva patients required additional surgery within five years, most converting to fusion.
- Surgeons reported radiographic signs of implant subsidence (sinking into the bone) in up to 80% of failed cases.
- Many revision patients lost bone stock, making later fusion procedures more complicated and requiring bone grafting.
By comparison, long-term data on toe fusion shows success rates exceeding 90%, with durable pain relief and patient satisfaction lasting more than a decade. For patients still uncertain whether their device is failing, see our guide on how to tell if your Cartiva implant is failing.
Why Surgeons Are Saying “Go Back to Basics”
After years of managing revision cases, many surgeons have stopped offering Cartiva altogether. Instead, they are returning to fusion as the standard of care for advanced arthritis.
Surgeons also point out that motion preservation with Cartiva often came at the expense of stability. Many patients ended up losing both-motion and comfort-after the implant failed. In contrast, a successful fusion creates a solid, pain-free joint that allows a nearly normal gait for most daily activities.
Comparing the Pros and Cons
| Feature | Cartiva Implant | Toe Fusion |
|---|---|---|
| Pain Relief | Often temporary; high recurrence after failure | Consistent and long-term |
| Mobility | Preserves motion initially but often decreases over time | Eliminates motion but improves stability and comfort |
| Failure Risk | High (shrinkage, migration, or fracture of implant) | Low (fusion success rates over 90%) |
| Revision Surgery | Common; may require bone graft or fusion later | Rare once fusion heals |
| Recovery Time | Short-term faster recovery but high chance of reoperation | Longer initial recovery but durable results |
Patient Outcomes and Quality of Life
For patients dealing with severe arthritis, both options can relieve pain-but the difference lies in predictability. Patients who undergo fusion often report stable, pain-free walking and return to normal activities within a few months. Those who received Cartiva implants and later required revision surgeries frequently face longer recoveries and permanent stiffness. These outcomes have become central in ongoing litigation, described in Inside the Cartiva Lawsuits.
When Fusion Makes Sense
Fusion is typically recommended for patients with advanced arthritis, severe cartilage loss, or deformity of the big toe joint. While it eliminates motion, it also eliminates the pain that comes from grinding bone on bone. Fusion is especially effective for patients who need lasting stability-those who are active, on their feet all day, or have already experienced an implant failure. To learn more about what to do if your implant failed, review Cartiva Implant Failed – What Patients Wish They Knew Before Surgery.
Modern fusion techniques use low-profile plates and screws that make recovery smoother and faster than in the past. Once healed, most patients can return to normal shoes and pain-free walking. Running or high-impact sports may be limited, but daily activities are fully manageable.
Legal and Medical Implications After Cartiva Failure
The rise in revision surgeries has not only changed medical recommendations-it has also led to widespread litigation. Patients who experienced Cartiva implant failure may qualify to file lawsuits against Stryker for selling a defective device and failing to warn of known risks. Compensation may cover medical bills, lost income, and pain and suffering associated with revision surgery and long-term limitations. Learn more about potential damages and time limits in Is It Too Late to File a Cartiva Lawsuit?.
Understanding the difference between Cartiva and fusion is not just about surgical outcomes-it’s also about patient rights. Those who trusted a defective product deserve both medical recovery and legal accountability.
Choosing the Right Path Forward
For patients facing revision decisions, it’s important to discuss options with an experienced orthopedic or podiatric surgeon. Many who once favored Cartiva now recommend fusion as the gold standard for predictable, long-term relief. Ask about outcomes, recovery expectations, and how your specific case fits the latest data. For additional insights into the broader impact of the recall, see Why the Cartiva Recall Could Be Bigger Than Anyone Expected.
As the medical community continues to re-evaluate the promises of synthetic cartilage implants, one thing is clear: sometimes, going back to basics is the best way forward.
Injured by a Failed Cartiva Implant? Call Alonso Krangle, LLP Today
If your Cartiva Synthetic Cartilage Implant failed or you’re experiencing pain, swelling, or stiffness after surgery, Alonso Krangle, LLP can help. Our attorneys represent patients nationwide in claims against Stryker and Cartiva, holding them accountable for defective medical devices that cause lasting harm.
Call [PHONE] or contact Alonso Krangle, LLP for a free, no-obligation consultation. There are no upfront fees, and you pay nothing unless we win your case.
Speak with An Attorney
Submit This Form or Call 800-403-6191